(AMM) Almaden Minerals - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA0202833053
AMM: Gold, Silver
Almaden Minerals Ltd., an exploration-stage company, focuses on the acquisition, exploration, evaluation, and development of mineral properties in Mexico. The companys primary asset is the Ixtaca gold-silver project, located in Puebla State, Mexico, where it holds a 100% interest. The Ixtaca project is a significant gold-silver deposit with measured and indicated resources of 1.96 million ounces of gold and 36.05 million ounces of silver, with additional inferred resources of 0.35 million ounces of gold and 7.94 million ounces of silver. The project has undergone a preliminary economic assessment, which outlined a potential open-pit mining operation with an estimated 11-year mine life, producing approximately 90,000 ounces of gold and 1.3 million ounces of silver annually. Almaden Minerals Ltd. was incorporated in 1980 and is headquartered in Vancouver, Canada.
The company is currently in the development stage, with a focus on advancing the Ixtaca project toward production. Almaden has faced challenges in recent years, including regulatory and environmental permitting issues, which have delayed the projects progression. Despite these challenges, the company remains committed to developing the Ixtaca project, which is considered one of its most promising assets. Almadens strategy includes ongoing exploration and development activities, as well as potential partnerships or joint ventures to advance the project.
From a technical perspective, the stock is currently trading near its SMA 200 of 0.08, suggesting potential support at this level. The SMA 20 and SMA 50 are both at 0.11, indicating a recent uptrend that has leveled off. The ATR of 0.01 reflects low volatility, while the average 20-day volume of 27,850 shares indicates moderate trading activity. The stocks last price of 0.09 is slightly below the SMA 20 and SMA 50, suggesting short-term weakness.
Fundamentally, Almaden Minerals Ltd. has a market capitalization of 7.55M CAD, with a price-to-book ratio of 3.38, indicating that the stock is trading at a premium to its book value. The companys price-to-earnings and forward P/E ratios are not applicable due to a lack of earnings. The lack of revenue and earnings reflects the companys status as an exploration-stage entity, with its value primarily tied to the potential of the Ixtaca project.
Additional Sources for AMM Stock
AMM Stock Overview
Market Cap in USD | 5m |
Sector | Basic Materials |
Industry | Gold |
GiC Sub-Industry | Gold |
IPO / Inception |
AMM Stock Ratings
Growth 5y | -78.1% |
Fundamental | -17.1% |
Dividend | 0.0% |
Rel. Strength Industry | -41.7 |
Analysts | - |
Fair Price Momentum | 0.07 CAD |
Fair Price DCF | - |
AMM Dividends
No Dividends PaidAMM Growth Ratios
Growth Correlation 3m | 63% |
Growth Correlation 12m | -46% |
Growth Correlation 5y | -94.4% |
CAGR 5y | -23.31% |
CAGR/Max DD 5y | -0.24 |
Sharpe Ratio 12m | -0.03 |
Alpha | -46.70 |
Beta | 0.21 |
Volatility | 218.83% |
Current Volume | 18k |
Average Volume 20d | 27.9k |
As of March 15, 2025, the stock is trading at CAD 0.11 with a total of 18,000 shares traded.
Over the past week, the price has changed by -4.55%, over one month by -12.50%, over three months by +0.00% and over the past year by -44.74%.
Neither. Based on ValueRay Fundamental Analyses, Almaden Minerals is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.05 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMM as of March 2025 is 0.07. This means that AMM is currently overvalued and has a potential downside of -36.36%.
Almaden Minerals has no consensus analysts rating.
According to ValueRays Forecast Model, AMM Almaden Minerals will be worth about 0.1 in March 2026. The stock is currently trading at 0.11. This means that the stock has a potential downside of -27.27%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 1.6 | 1309.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 0.1 | -27.3% |